SCHEMBL21851186

SCHEMBL21851186

CN1C(=O)C2(CCOCC2)c2c1cnc1cc(Cl)c(-c3ccc(F)nc3)cc21

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ PRKDC P78527 5/20 0.41
▸ ATM Q13315 8/20 0.37
▸ SSTR2 P30874 1/20 0.36
▸ PIK3CA P42336 3/20 0.36
▸ MTOR P42345 2/20 0.36
▸ KCNH2 Q12809 4/20 0.33
▸ SSTR5 P35346 1/20 0.32
▸ CNR2 P34972 2/20 0.31
▸ KRAS P01116 1/20 0.31
▸ BDKRB1 P46663 1/20 0.31
▸ PRKAB2 O43741 1/20 0.31
▸ PRKAG1 P54619 1/20 0.31
▸ PRKAA2 P54646 1/20 0.31
▸ PRKAA1 Q13131 1/20 0.31
▸ PRKAG3 Q9UGI9 1/20 0.31
▸ PRKAG2 Q9UGJ0 1/20 0.31
▸ PRKAB1 Q9Y478 1/20 0.31
▸ MOK Q9UQ07 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21851173 0.91 PRKDC (0.49) PRKDCATMPIK3CAMTORKCNH2
SCHEMBL21851167 0.86 ATM (0.46) PRKDCATMPIK3CAMTORKCNH2
SCHEMBL21851171 0.82 ATM (0.54) PRKDCATMPIK3CAMTORKCNH2
SCHEMBL21851184 0.80 PRKDC (0.38) PRKDCATM
SCHEMBL21851113 0.78 ATM (0.41) PRKDCATMPIK3CAMTORKCNH2
SCHEMBL21851224 0.76 PRKDC (0.42) PRKDCATMPIK3CAMTOR
SCHEMBL21851056 0.75 ATM (0.46) PRKDCATMPIK3CAMTORKCNH2
SCHEMBL21851073 0.73 ATM (0.44) PRKDCATMPIK3CAMTOR
SCHEMBL21851119 0.73 ACVR1 (0.48) PRKDCATMPIK3CAMTOR
SCHEMBL21494350 0.73 PRKDC (0.41) PRKDCATMPIK3CAMTOR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3845532-B1 QUINOLINO-PYRROLIDIN-2-ONE DERIVATIVE AND APPLICATION THEREOF MEDSHINE DISCOVERY INC (CN) 2022-12-21 — — EP disclosed
US-11230549-B2 Quinolino-pyrrolidin-2-one derivative and application thereof MEDSHINE DISCOVERY INC. (CN) 2022-01-25 — — US disclosed
US-20210380599-A1 QUINOLINO-PYRROLIDIN-2-ONE DERIVATIVE AND APPLICATION THEREOF MEDSHINE DISCOVERY INC. (CN) 2021-12-09 — — US disclosed
EP-3845532-A1 QUINOLINO-PYRROLIDIN-2-ONE DERIVATIVE AND APPLICATION THEREOF Medshine Discovery Inc. (CN) 2021-07-07 — — EP disclosed
WO-2020063855-A1 QUINOLINO-PYRROLIDIN-2-ONE DERIVATIVE AND APPLICATION THEREOF 南京明德新药研发有限公司 2020-04-02 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11230549-B2 Quinolino-pyrrolidin-2-one derivative and application thereof ATM, CHEK2, CHEK1 PRKDC 227/4885ATM 1/4885SSTR2 4184/4885
US-20210380599-A1 QUINOLINO-PYRROLIDIN-2-ONE DERIVATIVE AND APPLICATION THEREOF ATM, CHEK2, CHEK1 PRKDC 227/4885ATM 1/4885SSTR2 4184/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback